Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 362

1.

Elevated minimum inhibitory concentrations to antifungal drugs prevail in 14 rare species of candidemia-causing Saccharomycotina yeasts.

Stavrou AA, Pérez-Hansen A, Lackner M, Lass-Flörl C, Boekhout T.

Med Mycol. 2020 Feb 10. pii: myaa005. doi: 10.1093/mmy/myaa005. [Epub ahead of print]

PMID:
32043147
2.

Invasive Pulmonary Aspergillosis treatment duration in haematology patients in Europe: an EFISG, IDWP-EBMT, EORTC-IDG, SEIFEM survey.

Lanternier F, Seidel D, Pagano L, Styczynski J, Mikulska M, Pulcini C, Maertens J, Munoz P, Garcia C, Rijnders B, Arendrup MC, Sabino R, Verissimo C, Gaustad P, Klimko N, Arikan-Akdagli S, Arsic V, Barac A, Skiada A, Klingspor L, Herbrecht R, Donnelly P, Cornely OA, Lass-Flörl C, Lortholary O.

Mycoses. 2020 Feb 3. doi: 10.1111/myc.13056. [Epub ahead of print]

PMID:
32009262
3.

Polymorphisms within the ARNT2 and CX3CR1 genes are associated with the risk of developing invasive aspergillosis.

Lupiañez CB, Martínez-Bueno M, Sánchez-Maldonado JM, Badiola J, Cunha C, Springer J, Lackner M, Segura-Catena J, Canet LM, Alcazar-Fuoli L, López-Nevot MA, Fianchi L, Aguado JM, Pagano L, López-Fernández E, Alarcón-Riquelme M, Potenza L, Gonçalves SM, Luppi M, Moratalla L, Solano C, Sampedro A, González-Sierra P, Cuenca-Estrella M, Lagrou K, Maertens JA, Lass-Flörl C, Einsele H, Vazquez L; PCRAGA Study Group, Loeffler J, Ríos-Tamayo R, Carvalho A, Jurado M, Sainz J.

Infect Immun. 2020 Jan 21. pii: IAI.00882-19. doi: 10.1128/IAI.00882-19. [Epub ahead of print]

PMID:
31964743
4.

Galactosaminogalactan secreted from Aspergillus fumigatus and Aspergillus flavus induces platelet activation.

Deshmukh H, Rambach G, Sheppard DC, Lee M, Hagleitner M, Hermann M, Würzner R, Lass-Flörl C, Speth C.

Microbes Infect. 2020 Jan 18. pii: S1286-4579(20)30006-X. doi: 10.1016/j.micinf.2019.12.004. [Epub ahead of print]

PMID:
31962135
5.

Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection.

Jenks JD, Rawlings SA, Garcia-Vidal C, Koehler P, Mercier T, Prattes J, Lass-Flörl C, Martin-Gomez MT, Buchheidt D, Pagano L, Gangneux JP, van de Veerdonk FL, Netea MG, Carvalho A, Hoenigl M.

J Fungi (Basel). 2019 Dec 16;5(4). pii: E116. doi: 10.3390/jof5040116. Review.

6.

Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature.

Seidel D, Hassler A, Salmanton-García J, Koehler P, Mellinghoff SC, Carlesse F, Cheng MP, Falces-Romero I, Herbrecht R, Jover Sáenz A, Klimko N, Mareş M, Lass-Flörl C, Soler-Palacín P, Wisplinghoff H, Cornely OA, Pana Z, Lehrnbecher T.

Int J Infect Dis. 2019 Dec 19;92:114-122. doi: 10.1016/j.ijid.2019.12.017. [Epub ahead of print]

7.

The leucine biosynthetic pathway is crucial for adaptation to iron starvation and virulence in Aspergillus fumigatus.

Orasch T, Dietl AM, Shadkchan Y, Binder U, Bauer I, Lass-Flörl C, Osherov N, Haas H.

Virulence. 2019 Dec;10(1):925-934. doi: 10.1080/21505594.2019.1682760.

8.

Turning the World Upside-Down in Cellulose for Improved Culturing and Imaging of Respiratory Challenges within a Human 3D Model.

Zaderer V, Hermann M, Lass-Flörl C, Posch W, Wilflingseder D.

Cells. 2019 Oct 21;8(10). pii: E1292. doi: 10.3390/cells8101292.

9.

Evaluation of a Novel Mitochondrial Pan-Mucorales Marker for the Detection, Identification, Quantification, and Growth Stage Determination of Mucormycetes.

Caramalho R, Madl L, Rosam K, Rambach G, Speth C, Pallua J, Larentis T, Araujo R, Alastruey-Izquierdo A, Lass-Flörl C, Lackner M.

J Fungi (Basel). 2019 Oct 11;5(4). pii: E98. doi: 10.3390/jof5040098.

10.

Antibiotic resistance of blood cultures in regional and tertiary hospital settings of Tyrol, Austria (2006-2015): Impacts & trends.

Kreidl P, Kirchner T, Fille M, Heller I, Lass-Flörl C, Orth-Höller D.

PLoS One. 2019 Oct 10;14(10):e0223467. doi: 10.1371/journal.pone.0223467. eCollection 2019.

11.

Genome Assemblies of Two Rare Opportunistic Yeast Pathogens: Diutina rugosa (syn. Candida rugosa) and Trichomonascus ciferrii (syn. Candida ciferrii).

Mixão V, Saus E, Hansen AP, Lass-Florl C, Gabaldón T.

G3 (Bethesda). 2019 Dec 3;9(12):3921-3927. doi: 10.1534/g3.119.400762.

12.

Diagnostic Performance of a Novel Multiplex PCR Assay for Candidemia among ICU Patients.

Fuchs S, Lass-Flörl C, Posch W.

J Fungi (Basel). 2019 Sep 17;5(3). pii: E86. doi: 10.3390/jof5030086.

13.

Minimal Inhibitory Concentration (MIC)-Phenomena in Candida albicans and Their Impact on the Diagnosis of Antifungal Resistance.

Binder U, Aigner M, Risslegger B, Hörtnagl C, Lass-Flörl C, Lackner M.

J Fungi (Basel). 2019 Sep 4;5(3). pii: E83. doi: 10.3390/jof5030083.

14.

The Emergence of Rare Clinical Aspergillus Species in Qatar: Molecular Characterization and Antifungal Susceptibility Profiles.

Salah H, Lackner M, Houbraken J, Theelen B, Lass-Flörl C, Boekhout T, Almaslamani M, Taj-Aldeen SJ.

Front Microbiol. 2019 Jul 30;10:1677. doi: 10.3389/fmicb.2019.01677. eCollection 2019.

15.

Respiratory specimens and the diagnostic accuracy of Aspergillus lateral flow assays (LFA-IMMY™): real-life data from a multicentre study.

Lass-Flörl C, Lo Cascio G, Nucci M, Camargo Dos Santos M, Colombo AL, Vossen M, Willinger B.

Clin Microbiol Infect. 2019 Dec;25(12):1563.e1-1563.e3. doi: 10.1016/j.cmi.2019.08.009. Epub 2019 Aug 22.

PMID:
31445208
16.

Hypoxia Decreases Diagnostic Biomarkers for Aspergillosis In Vitro.

Maurer E, Aigner M, Lass-Flörl C, Binder U.

J Fungi (Basel). 2019 Jul 11;5(3). pii: E61. doi: 10.3390/jof5030061.

17.

Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay.

Vatanshenassan M, Arastehfar A, Boekhout T, Berman J, Lass-Flörl C, Sparbier K, Kostrzewa M.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00554-19. doi: 10.1128/AAC.00554-19. Print 2019 Sep.

18.

Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology.

Rammaert B, Puyade M, Cornely OA, Seidel D, Grossi P, Husain S, Picard C, Lass-Flörl C, Manuel O, Le Pavec J, Lortholary O; SCEDO-LUNG collaborative group.

Transpl Infect Dis. 2019 Oct;21(5):e13141. doi: 10.1111/tid.13141. Epub 2019 Jul 22.

PMID:
31283872
19.

ECMM CandiReg-A ready to use platform for outbreaks and epidemiological studies.

Koehler P, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bretagne S, Klingspor L, Lagrou K, Meis JF, Rautemaa-Richardson R, Schelenz S, Hamprecht A, Koehler FC, Kurzai O, Salmanton-García J, Vehreschild JJ, Alanio A, Alastruey-Izquierdo A, Arsic Arsenijevic V, Gangneux JP, Gow NAR, Hadina S, Hamal P, Johnson E, Klimko N, Lass-Flörl C, Mares M, Özenci V, Papp T, Roilides E, Sabino R, Segal E, Talento AF, Tortorano AM, Verweij PE, Hoenigl M, Cornely OA; European Confederation of Medical Mycology (ECMM).

Mycoses. 2019 Oct;62(10):920-927. doi: 10.1111/myc.12963. Epub 2019 Aug 1.

20.

Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.

Cornely OA, Hoenigl M, Lass-Flörl C, Chen SC, Kontoyiannis DP, Morrissey CO, Thompson GR 3rd; Mycoses Study Group Education and Research Consortium (MSG-ERC) and the European Confederation of Medical Mycology (ECMM).

Mycoses. 2019 Sep;62(9):716-729. doi: 10.1111/myc.12960. Epub 2019 Jul 19. Review.

PMID:
31254420
21.

Antifungal resistance in Aspergillus terreus: A current scenario.

Vahedi Shahandashti R, Lass-Flörl C.

Fungal Genet Biol. 2019 Oct;131:103247. doi: 10.1016/j.fgb.2019.103247. Epub 2019 Jun 25. Review.

PMID:
31247322
22.

Antifungal susceptibility profiles of rare ascomycetous yeasts.

Pérez-Hansen A, Lass-Flörl C, Lackner M; Rare Yeast Study Group .

J Antimicrob Chemother. 2019 Sep 1;74(9):2649-2656. doi: 10.1093/jac/dkz231.

PMID:
31203366
23.

Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity.

Schönfeld M, Knackmuss U, Chandorkar P, Hörtnagl P, Hope TJ, Moris A, Bellmann-Weiler R, Lass-Flörl C, Posch W, Wilflingseder D.

Front Immunol. 2019 May 24;10:1123. doi: 10.3389/fimmu.2019.01123. eCollection 2019.

24.

Cryptic species of Aspergillus section Terrei display essential physiological features to cause infection and are similar in their virulence potential in Galleria mellonella.

Lackner M, Obermair J, Naschberger V, Raschbichler LM, Kandelbauer C, Pallua J, Metzlaff J, Furxer S, Lass-Flörl C, Binder U.

Virulence. 2019 Dec;10(1):542-554. doi: 10.1080/21505594.2019.1614382.

25.

The changing spectrum of Saccharomycotina yeasts causing candidemia: phylogeny mirrors antifungal susceptibility patterns for azole drugs and amphothericin B.

Stavrou AA, Lackner M, Lass-Flörl C, Boekhout T.

FEMS Yeast Res. 2019 Jun 1;19(4). pii: foz037. doi: 10.1093/femsyr/foz037.

PMID:
31158288
26.

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.

Napolioni V, Pariano M, Borghi M, Oikonomou V, Galosi C, De Luca A, Stincardini C, Vacca C, Renga G, Lucidi V, Colombo C, Fiscarelli E, Lass-Flörl C, Carotti A, D'Amico L, Majo F, Russo MC, Ellemunter H, Spolzino A, Mosci P, Brancorsini S, Aversa F, Velardi A, Romani L, Costantini C.

Front Immunol. 2019 May 7;10:890. doi: 10.3389/fimmu.2019.00890. eCollection 2019.

27.

Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.

Morio F, Lombardi L, Binder U, Loge C, Robert E, Graessle D, Bodin M, Lass-Flörl C, Butler G, Le Pape P.

J Antimicrob Chemother. 2019 Aug 1;74(8):2230-2238. doi: 10.1093/jac/dkz204.

PMID:
31106355
28.

Whole-Genome Sequencing of the Opportunistic Yeast Pathogen Candida inconspicua Uncovers Its Hybrid Origin.

Mixão V, Hansen AP, Saus E, Boekhout T, Lass-Florl C, Gabaldón T.

Front Genet. 2019 Apr 25;10:383. doi: 10.3389/fgene.2019.00383. eCollection 2019.

29.

Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients.

Aigner M, Wanner M, Kreidl P, Lass-Flörl C, Lackner M.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00138-19. doi: 10.1128/AAC.00138-19. Print 2019 Jun.

30.

How to make a fast diagnosis in invasive aspergillosis.

Lass-Flörl C.

Med Mycol. 2019 Apr 1;57(Supplement_2):S155-S160. doi: 10.1093/mmy/myy103. Review.

PMID:
30816965
31.

Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology.

Koehler P, Mellinghoff SC, Lagrou K, Alanio A, Arenz D, Hoenigl M, Koehler FC, Lass-Flörl C, Meis JF, Richardson M, Cornely OA.

J Antimicrob Chemother. 2019 Jun 1;74(6):1704-1712. doi: 10.1093/jac/dkz051.

PMID:
30770712
32.

Erratum to 'High-quality endoscope reprocessing decreases endoscope contamination' [Clinical Microbiology and Infection, Volume 24, Issue 10 (October 2018) Pages 1101.e1-1101.e6].

Decristoforo P, Kaltseis J, Fritz A, Edlinger M, Posch W, Wilflingseder D, Lass-Flörl C, Orth-Höller D; Tyrolean Endoscope Hygiene Surveillance Study Group∗.

Clin Microbiol Infect. 2019 Mar;25(3):396. doi: 10.1016/j.cmi.2019.01.020. Epub 2019 Feb 4. No abstract available.

PMID:
30731205
33.

Candida albicans Factor H Binding Molecule Hgt1p - A Low Glucose-Induced Transmembrane Protein Is Trafficked to the Cell Wall and Impairs Phagocytosis and Killing by Human Neutrophils.

Kenno S, Speth C, Rambach G, Binder U, Chatterjee S, Caramalho R, Haas H, Lass-Flörl C, Shaughnessy J, Ram S, Gow NAR, Orth-Höller D, Würzner R.

Front Microbiol. 2019 Jan 15;9:3319. doi: 10.3389/fmicb.2018.03319. eCollection 2018.

34.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

35.

Galactosaminogalactan (GAG) and its multiple roles in Aspergillus pathogenesis.

Speth C, Rambach G, Lass-Flörl C, Howell PL, Sheppard DC.

Virulence. 2019 Dec;10(1):976-983. doi: 10.1080/21505594.2019.1568174. Epub 2019 Jan 22.

PMID:
30667338
36.

Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria.

Beyer R, Spettel K, Zeller I, Lass-Flörl C, Achleitner D, Krause R, Apfalter P, Buzina W, Strauss J, Gregori C, Schüller C, Willinger B.

Mycoses. 2019 Apr;62(4):357-367. doi: 10.1111/myc.12892. Epub 2019 Feb 20.

PMID:
30636016
37.

Generation of A Mucor circinelloides Reporter Strain-A Promising New Tool to Study Antifungal Drug Efficacy and Mucormycosis.

Binder U, Navarro-Mendoza MI, Naschberger V, Bauer I, Nicolas FE, Pallua JD, Lass-Flörl C, Garre V.

Genes (Basel). 2018 Dec 7;9(12). pii: E613. doi: 10.3390/genes9120613.

38.

Novel multiplex real-time quantitative PCR detecting system approach for direct detection of Candida auris and its relatives in spiked serum samples.

Arastehfar A, Fang W, Daneshnia F, Al-Hatmi AM, Liao W, Pan W, Khan Z, Ahmad S, Rosam K, Lackner M, Lass-Flörl C, Hagen F, Boekhout T.

Future Microbiol. 2019 Jan;14:33-45. doi: 10.2217/fmb-2018-0227. Epub 2018 Dec 12.

39.

High percentage of microbial colonization of osteosynthesis material in clinically unremarkable patients.

Knabl L, Kuppelwieser B, Mayr A, Posch W, Lackner M, Coraҫa-Huber D, Danita A, Blauth M, Lass-Flörl C, Orth-Höller D.

Microbiologyopen. 2019 Mar;8(3):e00658. doi: 10.1002/mbo3.658. Epub 2018 Dec 3.

40.

Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.

Bassetti M, Scudeller L, Giacobbe DR, Lamoth F, Righi E, Zuccaro V, Grecchi C, Rebuffi C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, Azoulay E, Blot SI, Cornely OA, Lass-Flörl C, Koehler P, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Maertens J, Martin-Loeches I, Muñoz P, Kullberg BJ, Agvald-Ohman C, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Calandra T; from the Study Group for Infections in Critically Ill Patients (ESGCIP) and the Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID); European Society of Intensive Care Medicine (ESICM); European Confederation of Medical Mycology (ECMM); Mycoses Study Group Education and Research Consortium (MSGERC).

Mycoses. 2019 Apr;62(4):310-319. doi: 10.1111/myc.12869. Epub 2019 Jan 22.

PMID:
30426598
41.

YEAST PANEL multiplex PCR for identification of clinically important yeast species: stepwise diagnostic strategy, useful for developing countries.

Arastehfar A, Fang W, Pan W, Lackner M, Liao W, Badiee P, Zomorodian K, Badali H, Hagen F, Lass-Flörl C, Boekhout T.

Diagn Microbiol Infect Dis. 2019 Feb;93(2):112-119. doi: 10.1016/j.diagmicrobio.2018.09.007. Epub 2018 Sep 21.

42.

β-1,3-glucan-lacking Aspergillus fumigatus mediates an efficient antifungal immune response by activating complement and dendritic cells.

Steger M, Bermejo-Jambrina M, Yordanov T, Wagener J, Brakhage AA, Pittl V, Huber LA, Haas H, Lass-Flörl C, Posch W, Wilflingseder D.

Virulence. 2019 Dec;10(1):957-969. doi: 10.1080/21505594.2018.1528843. Epub 2018 Oct 29.

PMID:
30372658
43.

Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.

Lackner M, Birch M, Naschberger V, Grässle D, Beckmann N, Warn P, Gould J, Law D, Lass-Flörl C, Binder U.

J Antimicrob Chemother. 2018 Nov 1;73(11):3068-3073. doi: 10.1093/jac/dky329.

PMID:
30351438
44.

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, Chen YC, Chen Y, Chryssanthou E, Dannaoui E, Garcia-Effron G, Gonzalez GM, Govender NP, Guinea J, Kidd S, Lackner M, Lass-Flörl C, Linares-Sicilia MJ, López-Soria L, Magobo R, Pelaez T, Quindós G, Rodriguez-Iglesia MA, Ruiz MA, Sánchez-Reus F, Sanguinetti M, Shields R, Szweda P, Tortorano A, Wengenack NL, Bramati S, Cavanna C, DeLuca C, Gelmi M, Grancini A, Lombardi G, Meletiadis J, Negri CE, Passera M, Peman J, Prigitano A, Sala E, Tejada M.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01651-18. doi: 10.1128/AAC.01651-18. Print 2019 Jan.

45.

Candida: Platelet Interaction and Platelet Activity in vitro.

Eberl C, Speth C, Jacobsen ID, Hermann M, Hagleitner M, Deshmukh H, Ammann CG, Lass-Flörl C, Rambach G.

J Innate Immun. 2019;11(1):52-62. doi: 10.1159/000491030. Epub 2018 Sep 3.

46.

Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.

Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Flörl C, Cornely OA; European Confederation of Medical Mycology (ECMM).

Mycoses. 2018 Nov;61(11):885-894. doi: 10.1111/myc.12836. Epub 2018 Aug 28.

PMID:
30086186
47.

Control of hospital-acquired infections in Austria.

Kuppelwieser B, Berktold M, Orth-Höller D, Lass-Flörl C.

Wien Klin Wochenschr. 2018 Nov;130(21-22):673-679. doi: 10.1007/s00508-018-1369-1. Epub 2018 Aug 2. No abstract available.

PMID:
30073546
48.

Outbreak report: a nosocomial outbreak of vancomycin resistant enterococci in a solid organ transplant unit.

Kreidl P, Mayr A, Hinterberger G, Berktold M, Knabl L, Fuchs S, Posch W, Eschertzhuber S, Obwegeser A, Lass-Flörl C, Orth-Höller D.

Antimicrob Resist Infect Control. 2018 Jul 18;7:86. doi: 10.1186/s13756-018-0374-5. eCollection 2018.

49.

Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.

Vatanshenassan M, Boekhout T, Lass-Flörl C, Lackner M, Schubert S, Kostrzewa M, Sparbier K.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00420-18. doi: 10.1128/JCM.00420-18. Print 2018 Sep.

50.

Treatment of Infections Due to Aspergillus terreus Species Complex.

Lass-Flörl C.

J Fungi (Basel). 2018 Jul 9;4(3). pii: E83. doi: 10.3390/jof4030083. Review.

Supplemental Content

Loading ...
Support Center